Maravai LifeSciences Holdings (NASDAQ:MRVI) is scheduled to announce Q4 earnings results on Tuesday, February 25th, after market close. The consensus EPS Estimate is -$0.04 (+95.0% Y/Y) and the ...
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today that it has completed its previously announced ...
DENTSPLY SIRONA Inc. XRAY is scheduled to release fourth-quarter 2024 results on Feb. 27, before the opening bell. Stay up-to ...
Bleakley Financial Group LLC lifted its position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Free Report) by 30.1% in the fourth quarter, HoldingsChannel.com reports. The firm owned 41,691 ...
In a report released today, Brandon Couillard from Wells Fargo maintained a Buy rating on Maravai Lifesciences Holdings (MRVI – Research ...